Can Lactobacillus (a type of probiotic) help with diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lactobacillus for Diarrhea: Evidence-Based Recommendations

Specific Lactobacillus strains can effectively reduce the duration and severity of diarrhea, particularly in antibiotic-associated and acute infectious diarrhea, with Saccharomyces boulardii and Lactobacillus rhamnosus GG showing the strongest evidence of efficacy. 1

Efficacy of Lactobacillus in Different Types of Diarrhea

Antibiotic-Associated Diarrhea

  • The American Gastroenterological Association (AGA) suggests using specific probiotics for prevention of antibiotic-associated diarrhea: 2

    • Saccharomyces boulardii
    • The 2-strain combination of L. acidophilus CL1285 and L. casei LBC80R
    • The 3-strain combination of L. acidophilus, L. delbrueckii subsp bulgaricus, and B. bifidum
    • The 4-strain combination of L. acidophilus, L. delbrueckii subsp bulgaricus, B. bifidum, and S. salivarius subsp thermophilus
  • Dosage is critical - higher doses (≥10 billion CFU/day) show better efficacy 1

Acute Infectious Diarrhea

  • The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) recommends: 2

    • Saccharomyces boulardii CNCM I-745
    • Lactobacillus rhamnosus GG
    • Lactobacillus reuteri DSM 17938
  • These probiotics can reduce diarrhea duration by approximately 21.91 hours and decrease the risk of prolonged diarrhea (>3 days) by 38% 1

Clostridium difficile-Associated Diarrhea

  • Evidence suggests S. boulardii may increase cessation of diarrhea (RR, 1.33; 95% CI, 1.02-1.74) and decrease recurrence (RR, 0.59; 95% CI, 0.35-0.98) 2
  • However, the AGA notes that current evidence is heterogeneous and of low quality 2

Strain-Specific Efficacy

Not all Lactobacillus strains are equally effective:

  1. Most Effective Strains:

    • Lactobacillus rhamnosus GG - strong evidence for prevention of nosocomial diarrhea and treatment of acute gastroenteritis 2
    • Saccharomyces boulardii - effective for antibiotic-associated diarrhea and C. difficile infection 2, 3
    • Lactobacillus reuteri - effective for acute gastroenteritis, especially in breastfed infants with colic 2, 4
  2. Less Effective or Uncertain:

    • Lactobacillus acidophilus - showed no significant benefit in some studies 5, 6
    • Lactobacillus rhamnosus ATCC 53103 - may actually increase recurrence of C. difficile infection 2

Dosage and Administration

  • Effective dosage: ≥10 billion CFU/day 1, 3
  • Timing: Should be taken 2 hours apart from antibiotics when used for antibiotic-associated diarrhea 1
  • Duration: Continue throughout antibiotic course and for 1-2 weeks after completion 1
  • Multi-strain probiotics often demonstrate better outcomes than single-strain options 1, 7

Safety Considerations

  • Generally safe with low adverse event rates (4% in probiotic groups vs 6% in control groups) 1
  • Use with caution in:
    • Premature neonates
    • Immunocompromised patients
    • Critically ill patients
    • Patients with central venous catheters
    • Patients with cardiac valvular disease
    • Patients with short-gut syndrome 2

Clinical Algorithm for Probiotic Selection

  1. For antibiotic-associated diarrhea prevention:

    • First choice: S. boulardii or L. rhamnosus GG at ≥10 billion CFU/day
    • Alternative: Multi-strain combinations as recommended by AGA
  2. For acute infectious diarrhea treatment:

    • First choice: L. rhamnosus GG or S. boulardii at ≥10 billion CFU/day
    • Alternative: L. reuteri (especially in breastfed infants)
  3. For C. difficile infection:

    • Consider S. boulardii as adjunct to appropriate antibiotic therapy
    • Avoid L. rhamnosus ATCC 53103 due to potential increased recurrence
  4. For high-risk patients (immunocompromised, critically ill):

    • Avoid probiotics due to safety concerns

Remember that rehydration remains the primary treatment for diarrhea, with probiotics serving as adjunctive therapy 1.

References

Guideline

Treatment of Diarrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Probiotics for prevention and treatment of diarrhea.

Journal of clinical gastroenterology, 2011

Research

Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children.

Journal of pediatric gastroenterology and nutrition, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.